Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7RJF

MOPD-1 mutant-L47W

Summary for 7RJF
Entry DOI10.2210/pdb7rjf/pdb
Descriptor[L47W]MOPD-1, ZINC ION, MALONATE ION, ... (4 entities in total)
Functional Keywordssynthetic peptide, disulfide-rich peptide, antitumor peptide, peptide mimetic, antitumor protein
Biological sourcesynthetic construct
Total number of polymer chains2
Total formula weight11934.23
Authors
Huawu, Y.,Conan, K.W.,Gordon, J.K.,Brett, M.C.,Yen-Hua, H.,David, J.C. (deposition date: 2021-07-20, release date: 2021-10-27, Last modification date: 2024-10-23)
Primary citationYin, H.,Zhou, X.,Huang, Y.H.,King, G.J.,Collins, B.M.,Gao, Y.,Craik, D.J.,Wang, C.K.
Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy.
J.Am.Chem.Soc., 143:18536-18547, 2021
Cited by
PubMed Abstract: Peptides have potential to be developed into immune checkpoint inhibitors, but the target interfaces are difficult to inhibit. Here, we explored an approach to mimic the binding surface of PD-1 to design inhibitors. Mimicking native PD-1 resulted in a mimetic with no activity. However, mimicking an affinity-optimized PD-1 resulted in the peptide mimetic MOPD-1 that displayed nanomolar affinity to PD-L1 and could inhibit PD-1:PD-L1 interactions in both protein- and cell-based assays. Mutagenesis and structural characterization using NMR spectroscopy and X-ray crystallography revealed that binding residues from the high affinity PD-1 are crucial for the bioactivity of MOPD-1. Furthermore, MOPD-1 was extremely stable in human serum and inhibited tumor growth , suggesting it has potential for use in cancer immunotherapy. The successful design of an inhibitor of PD-1:PD-L1 using the mimicry approach described herein illustrates the value of placing greater emphasis on optimizing the target interface before inhibitor design and is an approach that could have broader utility for the design of peptide inhibitors for other complex protein-protein interactions.
PubMed: 34661406
DOI: 10.1021/jacs.1c08132
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

250835

PDB entries from 2026-03-18

PDB statisticsPDBj update infoContact PDBjnumon